Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001213900-17-007985
Filing Date
2017-07-27
Accepted
2017-07-27 17:21:31
Documents
53

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs42017_ophthalixinc.htm S-4 4171880
2 FORM OF OPINION OF MCDERMOTT WILL & EMERY LLP REGARDING LEGALITY OF SECURITIES B fs42017ex5i_ophthalixinc.htm EX-5.1 16039
3 EXCLUSIVE DISTRIBUTION AND LICENSING AGREEMENT DATED MAY 1, 2015 BETWEEN RESDEVC fs42017ex10-09_ophthalix.htm EX-10.9 182276
4 AMENDMENT TO LICENSING AGREEMENT DATED NOVEMBER 22, 2015 BETWEEN RESDEVCO LTD. A fs42017ex10-10_ophthalix.htm EX-10.10 14572
5 AMENDMENT NO. 2 TO LICENSING AGREEMENT DATED MARCH 20, 2016 BETWEEN RESDEVCO LTD fs42017ex10-11_ophthalix.htm EX-10.11 14022
6 AMENDMENT NO. 1 TO LICENSING AGREEMENT - ISRAELI MARKET DATED MAY 31, 2016 BETWE fs42017ex10-12_ophthalix.htm EX-10.12 26431
7 AMENDMENT NO. 2 TO LICENSING AGREEMENT - UKRAINE MARKET DATED MAY 31, 2016 BETWE fs42017ex10-13_ophthalixinc.htm EX-10.13 17017
8 ADDITION TO AMENDMENT TO LICENSING AGREEMENT DATED JANUARY 6, 2017 BETWEEN RESDE fs42017ex10-15_ophthalixinc.htm EX-10.15 8444
9 SECOND ADDITION TO AMENDMENT TO LICENSING AGREEMENT DATED MARCH 30, 2017 BETWEEN fs42017ex10-16_ophthalixinc.htm EX-10.16 11907
10 CORRECTION TO LICENSING AGREEMENT DATED JUNE 16, 2017 BETWEEN RESDEVCO LTD. AND fs42017ex10-17_ophthalixinc.htm EX-10.17 7636
11 APPENDIX F TO EXCLUSIVE DISTRIBUTION AND LICENSING AGREEMENT BETWEEN RESDEVCO LT fs42017ex10-18_ophthalix.htm EX-10.18 8289
12 APPENDIX G. TO THE EXCLUSIVE DISTRIBUTION AND LICENSING AGREEMENT, DATED MAY 1, fs42017ex10-19_ophthalix.htm EX-10.19 4436
13 ASSUMPTION AGREEMENT DATED AUGUST 30, 2016 BETWEEN RESDEVCO LTD. AND OCUWIZE LTD fs42017ex10-20_ophthalixinc.htm EX-10.20 23898
14 CONVERTIBLE LOAN AGREEMENT DATED MARCH 20, 2016 BETWEEN WIZE PHARMA LTD. AND RIM fs42017ex10-21_ophthalixinc.htm EX-10.21 192230
15 ADDENDUM TO CONVERTIBLE LOAN AGREEMENT DATED MARCH 30, 2016 BETWEEN WIZE PHARMA fs42017ex10-22_ophthalixinc.htm EX-10.22 27452
16 SECOND CONVERTIBLE LOAN AGREEMENT DATED JANUARY 12, 2017 BETWEEN WIZE PHARMA LTD fs42017ex10-23_ophthalixinc.htm EX-10.23 201189
17 DEBENTURE FLOATING CHARGE DATED MARCH 20, 2016 BETWEEN WIZE PHARMA LTD. AND RIMO fs42017ex10-24_ophthalixi.htm EX-10.24 139792
18 DEBENTURE - FIXED CHARGE DATED MARCH 20, 2016 BETWEEN WIZE PHARMA LTD. AND RIMON fs42017ex10-25_ophthalixinc.htm EX-10.25 111375
19 DEBENTURE FLOATING CHARGE DATED OCTOBER 26, 2016 BETWEEN OCU WIZE LTD. AND RIMON fs42017ex10-26_ophthalixinc.htm EX-10.26 141990
20 DEBENTURE - FIXED CHARGE DATED OCTOBER 26 2016 BETWEEN OCU WIZE LTD. AND RIMON G fs42017ex10-27_ophthalixinc.htm EX-10.27 121707
21 AMENDMENT TO DEBENTURE - FLOATING CHARGE DATED MARCH 28, 2017 BETWEEN WIZE PHARM fs42017ex10-28_ophthalix.htm EX-10.28 24790
22 AMENDMENT TO DEBENTURE - FIXED CHARGE DATED MARCH 28, 2017 BETWEEN WIZE PHARMA L fs42017ex10-29_ophthalix.htm EX-10.29 17603
23 AMENDMENT TO DEBENTURE - FLOATING CHARGE DATED MARCH 28, 2017 BETWEEN OCU WIZE L fs42017ex10-30_ophthalixinc.htm EX-10.30 24879
24 AMENDMENT TO DEBENTURE - FIXED CHARGE DATED MARCH 28, 2017 BETWEEN OCU WIZE LTD. fs42017ex10-31_ophthalix.htm EX-10.31 21695
25 FORM OF IRREVOCABLE GUARANTY AND UNDERTAKING fs42017ex10-32_ophthalix.htm EX-10.32 37944
26 PRIVATE PLACEMENT AGREEMENT DATED MAY 25,2017 BETWEEN WIZE PHARMA LTD. AND JONAT fs42017ex10-33_ophthalix.htm EX-10.33 50237
27 ADDENDUM TO PRIVATE PLACEMENT AGREEMENT DATED JUNE 15, 2017 BETWEEN WIZE PHARMA fs42017ex10-34_ophthalix.htm EX-10.34 5558
28 PRIVATE PLACEMENT AGREEMENT DATED JUNE 23, 2017 BETWEEN WIZE PHARMA LTD. AND SIM fs42017ex10-35_ophthalix.htm EX-10.35 36021
29 PRIVATE PLACEMENT AGREEMENT DATED JUNE 23, 2017 BETWEEN WIZE PHARMA LTD. AND YAA fs42017ex10-36_ophthalix.htm EX-10.36 38153
30 PRIVATE PLACEMENT AGREEMENT DATED JUNE 23, 2017 BETWEEN WIZE PHARMA LTD. AND PER fs42017ex10-37_ophthalix.htm EX-10.37 35331
31 EMPLOYMENT AGREEMENT DATED SEPTEMBER 30, 2015 BETWEEN WIZE PHARMA LTD. AND OR EI fs42017ex10-38_ophthalix.htm EX-10.38 162597
32 AGREEMENT FOR PROVISION OF SERVICES AGREEMENT DATED SEPTEMBER 30, 2015 BETWEEN W fs42017ex10-39_ophthalix.htm EX-10.39 160382
33 AGREEMENT FOR PROVISION OF SERVICES AGREEMENT DATED SEPTEMBER 30, 2015 BETWEEN W fs42017ex10-40_ophthalix.htm EX-10.40 148995
34 FINDER'S AGREEMENT DATED JUNE 19, 2017 BETWEEN WIZE PHARMA LTD. AND HARBIN ISRAE fs42017ex10-41_ophthalix.htm EX-10.41 34690
35 SUBSIDIARIES OF OPHTHALIX, INC. fs42017ex21-1_ophthalix.htm EX-21.1 1160
36 SUBSIDIARIES OF WIZE PHARMA LTD. fs42017ex21-2_ophthalix.htm EX-21.2 1352
37 CONSENT OF KOST, FORER, GABBAY AND KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL fs42017ex23-1_ophthalix.htm EX-23.1 3836
38 CONSENT OF FAHN KANNE & CO GRANT THORNTON ISRAEL fs42017ex23ii_ophthalixinc.htm EX-23.2 4718
39 CONSENT OF PULVERNIS BAREKET BEN YEHUDA LTD. fs42017ex99-03_ophthalix.htm EX-99.3 8833
40 CONSENT OF RON MAYRON fs42017ex99-05_ophthalix.htm EX-99.5 4291
41 CONSENT OF YOSSI KERET fs42017ex99-06_ophthalix.htm EX-99.6 4102
42 CONSENT OF FRANCK AMOUYAL fs42017ex99-07_ophthalix.htm EX-99.7 4056
43 CONSENT OF JOSEPH ZARZEWSKY fs42017ex99-08_ophthalix.htm EX-99.8 2620
44 GRAPHIC ex10ix_001.jpg GRAPHIC 19353
45 GRAPHIC ex10ix_002.jpg GRAPHIC 126002
46 GRAPHIC ex23ii.jpg GRAPHIC 16378
47 GRAPHIC ex5i.jpg GRAPHIC 10415
48 GRAPHIC image_001.jpg GRAPHIC 3300
49 GRAPHIC img01_ex13vii.jpg GRAPHIC 9683
50 GRAPHIC img_01.jpg GRAPHIC 14004
51 GRAPHIC logo.jpg GRAPHIC 4887
52 GRAPHIC logo1.jpg GRAPHIC 3051
53 GRAPHIC dec_001.jpg GRAPHIC 13149
  Complete submission text file 0001213900-17-007985.txt   6582062
Mailing Address 10 BAREKET STREET PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET PETACH TIKVA L3 4951778 972 3 9241114
OphthaliX, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-219514 | Film No.: 17987117
SIC: 2834 Pharmaceutical Preparations